Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
Clinical Study

Repurposing drugs in oncology (ReDO)—selective PDE5 inhibitors as anti-cancer agents

Author Interview

Pan Pantziarka

Anticancer Fund, Brussels, Belgium

 

Read Dr Pantziarka's article here.



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation